Results 11 to 20 of about 18,796 (241)
Therapeutic Approaches to Dysautonomia in Childhood, with a Special Focus on Long COVID
Background: Dysautonomia seems to be important for the pathophysiology of psychosomatic diseases and, more recently, for long COVID. This concept may explain the clinical symptoms and could help open new therapeutic approaches.
Reiner Buchhorn
doaj +2 more sources
Long COVID-19 and Postural Orthostatic Tachycardia Syndrome- Is Dysautonomia to Be Blamed?
While the increased arrhythmic tendency during acute COVID-19 infection is recognised, the long-term cardiac electrophysiological complications are less well known.
Karan R. Chadda +5 more
doaj +2 more sources
Non-motor symptoms of Parkinson’s disease (PD) such as dysautonomia and REM sleep behavior disorder (RBD) are recognized to be important prodromal symptoms that may also indicate clinical subtypes of PD with different pathogenesis.
Giulietta Maria Riboldi +4 more
doaj +2 more sources
Background Guillain-Barré syndrome (GBS) presents with progressive ascending weakness, but it can also present with dysautonomia such as tachycardia, blood pressure fluctuations, diaphoresis, ileus, and urinary retention.
Gerald T. Pagaling +3 more
doaj +2 more sources
Dysautonomia following Lyme disease: a key component of post-treatment Lyme disease syndrome?
Dysautonomia, or dysfunction of the autonomic nervous system (ANS), may occur following an infectious insult and can result in a variety of debilitating, widespread, and often poorly recognized symptoms.
Brittany L. Adler +3 more
doaj +2 more sources
Background The association between autonomic dysfunction and long‐COVID syndrome is established. However, the prevalence and patterns of symptoms of dysautonomia in long‐COVID syndrome in a large population are lacking.
Ahmed M. Eldokla +9 more
doaj +2 more sources
Vagus nerve inflammation contributes to dysautonomia in COVID-19 [PDF]
Dysautonomia has substantially impacted acute COVID-19 severity as well as symptom burden after recovery from COVID-19 (long COVID), yet the underlying causes remain unknown.
Marcel S. Woo +19 more
openalex +2 more sources
Norepinephrine transporter defects lead to sympathetic hyperactivity in Familial Dysautonomia models [PDF]
Familial dysautonomia (FD), a rare neurodevelopmental and neurodegenerative disorder affects the sympathetic and sensory nervous system. Although almost all patients harbor a mutation in ELP1, it remains unresolved exactly how function of sympathetic ...
Hsueh‐Fu Wu +8 more
openalex +2 more sources
Severe Post-COVID-19 dysautonomia: a case report [PDF]
Background The emergence of dysautonomia as a consequence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; or COVID-19) is becoming more prevalent.
Joan Bosco, Ruwanthi Titano
openalex +2 more sources
Review of published research on primary dysautonomia of domestic animals. [PDF]
Harte T, Smith D, Moore J, Wells B.
europepmc +3 more sources

